Rationale and design of the PREVENT-HIT study: A randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis
James N. Frame, Lawrence Rice, John R. Bartholomew, Andrew Whelton
Dive into the research topics of 'Rationale and design of the PREVENT-HIT study: A randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis'. Together they form a unique fingerprint.